← Back to Search

Patient-Reported Outcome Measures for Coronary Artery Disease

N/A
Waitlist Available
Led By Stephen B Wilton, MD, MSc
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age at least 40 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patients will complete a post-visit survey following each visit during both the control and intervention period (~8 months).
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new online tool to measure & report quality of life & health status of patients with heart disease, to help physicians better manage their symptoms.

Who is the study for?
This trial is for adults over 40 with known or suspected coronary artery disease, who can communicate in English (or have help) and have internet access. They must be seeing a participating cardiologist soon.
What is being tested?
The study tests an electronic system where patients report their health status online, which then gets shared with their doctors to improve care for heart conditions.
What are the potential side effects?
Since this trial involves completing surveys rather than taking medication, there are no direct medical side effects. However, participants may experience inconvenience or privacy concerns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 40 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patients will complete a post-visit survey following each visit during both the control and intervention period (~8 months).
This trial's timeline: 3 weeks for screening, Varies for treatment, and patients will complete a post-visit survey following each visit during both the control and intervention period (~8 months). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability and utility of the ePROM Patient Survey and Clinician Report to patients
Acceptability of the Clinician Report to clinicians
ePROM usage metrics

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Patients in this group will complete the ePROM patient survey in advance of their care visit.
Group II: Control GroupActive Control1 Intervention
Patients in this group will attend their cardiology appointment as normal. No intervention present.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,529,242 Total Patients Enrolled
25 Trials studying Coronary Artery Disease
29,278 Patients Enrolled for Coronary Artery Disease
University of CalgaryLead Sponsor
810 Previous Clinical Trials
886,094 Total Patients Enrolled
11 Trials studying Coronary Artery Disease
10,596 Patients Enrolled for Coronary Artery Disease
Stephen B Wilton, MD, MScPrincipal InvestigatorAPPROACH Research Group, Libin Cardiovascular Institute, Cumming School of Medicine
~0 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top